NCT04242342View on ClinicalTrials.gov

Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors

NAActive, not recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 20, 2020

Primary Completion Date

January 20, 2029

Study Completion Date

January 20, 2029

Conditions
Radiotherapy
Interventions
RADIATION

Adaptative MR-Guided Stereotactic Body Radiotherapy

"If lesion near organs at risk:~* Prescription of 50 Gy in 5 fractions of 10 Gy~* 3 sessions per week, with MRI guided stereotactic radiotherapy and daily adaptive treatment~If lesion far of organs at risk:~* Prescription of 60 Gy in 6 fractions of 10 Gy~* 3 sessions per week, with MRI guided stereotactic radiotherapy without daily adaptive treatment"

Trial Locations (1)

21000

Centre Georges François Leclerc, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER